Factors associated with mortality in bacteremic patients with hematologic malignancies

Diagnostic Microbiology and Infectious Disease

Volumn 64, Issue 3, 2009, Pages 320-326

  Tumbarello, Mario ^a   Spanu, Teresa ^a   Caira, Morena ^a   Trecarichi, Enrico M ^a   Laurenti, Luca ^a   Montuori, Eva ^a   Fianchi, Luana ^a   Leone, Fiammetta ^a   Fadda, Giovanni ^a   Cauda, Roberto ^a   Pagano, Livio ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

Antimicrobial resistance; Bacteremia; Hematologic malignancies; Mortality

Indexed keywords

AMIKACIN; ANTIBIOTIC AGENT; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; CEFEPIME; CEFTAZIDIME; GENTAMICIN; IMIPENEM; MEROPENEM; METICILLIN; PIPERACILLIN PLUS TAZOBACTAM; VANCOMYCIN;

ACUTE KIDNEY FAILURE; ADULT; AGE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTEREMIA; BACTERIAL STRAIN; CANCER PATIENT; COHORT ANALYSIS; FEMALE; GRAM NEGATIVE BACTERIUM; GRAM POSITIVE BACTERIUM; HEMATOLOGIC MALIGNANCY; HOSPITAL INFECTION; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MALE; MALIGNANT NEOPLASTIC DISEASE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORTALITY; NEUTROPENIA; NONHUMAN; OVERALL SURVIVAL; PREDICTION; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK ASSESSMENT; RISK FACTOR; SURVIVAL TIME; VANCOMYCIN RESISTANT ENTEROCOCCUS;

BACTEREMIA; COHORT STUDIES; FEMALE; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HEMATOLOGIC NEOPLASMS; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS;

EID: 67349261983     PISSN: 07328893     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.diagmicrobio.2009.02.008     Document Type: Article

References (38)

1. Anderson D.J., Engemann J.J., Harrell L.J., Carmeli Y., Reller L.B., and Kaye K.S. Predictors of mortality in patients with bloodstream infection due to ceftazidime-resistant Klebsiella pneumoniae. Antimicrob. Agents Chemother. 50 (2006) 1715-1720
2. Benoit D.D., Vandewoude K.H., Decruyenaere J.M., Hoste E.A., and Colardyn F.A. Outcome and early prognostic indicators in patients with a hematologic malignancy admitted to the intensive care unit for a life-threatening complication. Crit. Care Med. 31 (2003) 104-112
3. Blot F., Guiguet M., Nitenberg G., Leclercq B., Gachot B., and Escudier B. Prognostic factors for neutropenic patients in an intensive care unit: respective roles of underlying malignancies and acute organ failures. Eur. J. Cancer 33 (1997) 1031-1037
4. Blot S., Vandewoude K., De Bacquer D., and Colardyn F. Nosocomial bacteremia caused by antibiotic-resistant Gram-negative bacteria in critically ill patients: clinical outcome and length of hospitalization. Clin. Infect. Dis. 34 (2002) 1600-1606
5. Chen C.Y., Tang J.L., Hsueh P.R., Yao M., Huang S.Y., Chen Y.C., Chen Y.C., Shen M.C., Wang C.H., Tsai W., Chang S.C., Tien H.F., and Luh K.T. Trends and antimicrobial resistance of pathogens causing bloodstream infections among febrile neutropenic adults with hematological malignancy. J. Formos. Med. Assoc. 103 (2004) 526-532
6. Clinical Laboratory Standards Institute (CLSI). Performance standards for antimicrobial susceptibility testing; Seventeenth Informational Supplement. M100-S17 (2007), CLSI, Wayne, PA, USA
7. Collin B.A., Leather H.L., Wingard J.R., and Ramphal R. Evolution, incidence, and susceptibility of bacterial bloodstream isolates from 519 bone marrow transplant patients. Clin. Infect. Dis. 33 (2001) 947-953
8. Cosgrove S.E. The relationship between antimicrobial resistance and patient outcomes: mortality, length of hospital stay, and health care costs. Clin. Infect. Dis. 42 Suppl 2 (2006) 82-89
9. Darmon M., Azoulay E., Alberti C., Fieux F., Moreau D., Le Gall J.R., and Schlemmer B. Impact of neutropenia duration on short-term mortality in neutropenic critically ill cancer patients. Intensive Care Med. 28 (2002) 1775-1780
10. EARSS/RIVM. The European Antimicrobial Resistance Surveillance System. http://www.rivm.nl/earss/database/ (10 April 2008, last date accessed)
11. Friedman N.D., Kaye K.S., Stout J.E., McGarry S.A., Trivette S.L., Briggs J.P., Lamm W., Clark C., MacFarquhar J., Walton A.L., Reller L.B., and Sexton D.J. Health care-associated bloodstream infections in adults: a reason to change the accepted definition of community-acquired infections. Ann. Intern. Med. 137 (2002) 791-797
12. Garner J.S., Jarvis W.R., Emori T.G., Horan T.C., and Hughes J.M. CDC definitions for nosocomial infections, 1988. Am. J. Infect. Control. 16 (1988) 128-140
13. Gaytán-Martínez J., Mateos-García E., Sánchez-Cortés E., González-Llaven J., Casanova-Cardiel L.J., and Fuentes-Allen J.L. Microbiological findings in febrile neutropenia. Arch. Med. Res. 31 (2000) 388-392
14. Giske C.G., Monnet D.L., Cars O., and Carmeli Y. Clinical and economic impact of common multidrug-resistant gram-negative bacilli. Antimicrob. Agents Chemother. 52 (2008) 813-821
15. Graham III P.L., Lin S.X., and Larson E.L. A U.S. population-based survey of Staphylococcus aureus colonization. Ann. Intern. Med. 144 (2006) 318-325
16. Guven G.S., Uzun O., Cakir B., Akova M., and Unal S. Infectious complications in patients with hematological malignancies consulted by the Infectious Diseases team: a retrospective cohort study (1997-2001). Support Care Cancer 14 (2006) 52-55
17. Homsi J., Walsh D., Panta R., Lagman R., Nelson K.A., and Longworth D.L. Infectious complications of advanced cancer. Support Care Cancer 8 (2000) 487-492
18. Hughes W.T., Armstrong D., Bodey G.P., Bow E.J., Brown A.E., Calandra T., Feld R., Pizzo P.A., Rolston K.V., Shenep J.L., and Young L.S. 2002 Guidelines for the use of antimicrobial agents in neutropenic patients with cancer. Clin. Infect. Dis. 34 (2002) 730-751
19. Klastersky J. Current attitudes for therapy of febrile neutropenia with consideration to cost-effectiveness. Curr. Opin. Oncol. 10 (1998) 284-290
20. Kollef M.H. Inadequate antimicrobial treatment: an important determinant of outcome for hospitalized patients. Clin. Infect. Dis. 31 Suppl 4 (2000) 131-138
21. Krcméry Jr. V., Spanik S., Krupova I., Trupl J., Kunova A., Smid M., and Pichnova E. Bacteremia due to multiresistant gram-negative bacilli in neutropenic cancer patients: a case controlled study. J. Chemother. 10 (1998) 320-325
22. Krupova I., Kaiserova E., Foltinova A., Kovacicova G., Kiskova M., Krchnakova A., Kunova A., Trupl J., West D., and Krcmery Jr. V. Bacteremia and fungemia in pediatric versus adult cancer patients after chemotherapy: comparison of etiology, risk factors and outcome. J. Chemother. 10 (1998) 236-242
23. Luzzaro F., Mezzatesta M., Mugnaioli C., Perilli M., Stefani S., Amicosante G., Rossolini G.M., and Toniolo A. Trends in production of extended-spectrum beta-lactamases among enterobacteria of medical interest: report of the second Italian nationwide survey. J. Clin. Microbiol. 44 (2006) 1659-1664
24. Madani T.A. Clinical infections and bloodstream isolates associated with fever in patients undergoing chemotherapy for acute myeloid leukemia. Infection 28 (2000) 367-373
25. Nicoletti G., Schito G., Fadda G., Boros S., Nicolosi D., Marchese A., Spanu T., Pantosti A., Monaco M., Rezza G., Cassone A., and Garaci E; C.I.G.A.R. Bacterial isolates from severe infections and their antibiotic susceptibility patterns in Italy: a nationwide study in the hospital setting. J. Chemother. 18 (2006) 589-602
26. Nørgaard M., Larsson H., Pedersen G., Schønheyder H.C., Rothman K.J., and Sørensen H.T. Short-term mortality of bacteraemia in elderly patients with haematological malignancies. Br. J. Haematol. 132 (2006) 25-31
27. Rodríguez-Baño J., Alcalá J.C., Cisneros J.M., Grill F., Oliver A., Horcajada J.P., Tórtola T., Mirelis B., Navarro G., Cuenca M., Esteve M., Peña C., Llanos A.C., Cantón R., and Pascual A. Community infections caused by extended-spectrum beta-lactamase-producing Escherichia coli. Arch. Intern. Med. 168 (2008) 1897-1902
28. Rolston K.V. The Infectious Diseases Society of America 2002 guidelines for the use of antimicrobial agents in patients with cancer and neutropenia: salient features and comments. Clin. Infect. Dis. 39 Suppl 1 (2004) 44-48
29. Russell J.A. Management of sepsis. N. Engl. J. Med. 355 (2006) 1699-1713
30. Safdar A., and Rolston K.V. Stenotrophomonas maltophilia: changing spectrum of a serious bacterial pathogen in patients with cancer. Clin. Infect. Dis. 45 (2007) 1602-1609
31. Schwaber M.J., and Carmeli Y. Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. J. Antimicrob. Chemother. 60 (2007) 913-920
32. Serody J.S. Fever in immunocompromised patients. N. Engl. J. Med. 342 (2000) 217-218
33. Tumbarello M., Sanguinetti M., Montuori E., Trecarichi E.M., Posteraro B., Fiori B., Citton R., D'Inzeo T., Fadda G., Cauda R., and Spanu T. Predictors of mortality in patients with bloodstream infections caused by extended-spectrum-beta-lactamase-producing Enterobacteriaceae: importance of inadequate initial antimicrobial treatment. Antimicrob. Agents Chemother. 51 (2007) 1987-1994
34. Velasco E., Byington R., Martins C.S., Schirmer M., Dias L.C., and Gonçalves V.M. Bloodstream infection surveillance in a cancer centre: a prospective look at clinical microbiology aspects. Clin. Microbiol. Infect. 10 (2004) 542-549
35. Venditti M., Falcone M., Micozzi A., Carfagna P., Taglietti F., Serra P.F., and Martino P. Staphylococcus aureus bacteremia in patients with hematologic malignancies: a retrospective case-control study. Haematologica 88 (2003) 923-930
36. Weinstein M.P., Towns M.L., Quartey S.M., Mirrett S., Reimer L.G., Parmigiani G., and Reller L.B. The clinical significance of positive blood cultures in the 1990s: a prospective comprehensive evaluation of the microbiology, epidemiology, and outcome of bacteremia and fungemia in adults. Clin. Infect. Dis. 24 (1997) 584-602
37. Wisplinghoff H., Cornely O.A., Moser S., Bethe U., Stützer H., Salzberger B., Fätkenheuer G., and Seifert H. Outcomes of nosocomial bloodstream infections in adult neutropenic patients: a prospective cohort and matched case-control study. Infect. Control Hosp. Epidemiol. 24 (2003) 905-911
38. Wisplinghoff H., Seifert H., Wenzel R.P., and Edmond M.B. Current trends in the epidemiology of nosocomial bloodstream infections in patients with hematological malignancies and solid neoplasms in hospitals in the United States. Clin. Infect. Dis. 36 (2003) 1103-1110